HUM Stock Overview
Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Humana Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$283.55 |
| 52 Week High | US$0 |
| 52 Week Low | US$0 |
| Beta | 0.46 |
| 1 Month Change | -0.60% |
| 3 Month Change | -18.52% |
| 1 Year Change | -40.95% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -43.01% |
Recent News & Updates
Recent updates
Shareholder Returns
| HUM | BG Healthcare | BG Market | |
|---|---|---|---|
| 7D | -2.0% | 2.3% | 0.6% |
| 1Y | -40.9% | -4.8% | 17.1% |
Return vs Industry: HUM underperformed the BG Healthcare industry which returned -4.8% over the past year.
Return vs Market: HUM underperformed the BG Market which returned 17.1% over the past year.
Price Volatility
| HUM volatility | |
|---|---|
| HUM Average Weekly Movement | 4.5% |
| Healthcare Industry Average Movement | 5.1% |
| Market Average Movement | 3.7% |
| 10% most volatile stocks in BG Market | 8.2% |
| 10% least volatile stocks in BG Market | 2.4% |
Stable Share Price: HUM's share price has been volatile over the past 3 months.
Volatility Over Time: HUM's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1961 | 67,600 | Bruce Broussard | www.humana.com |
Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals.
Humana Inc. Fundamentals Summary
| HUM fundamental statistics | |
|---|---|
| Market cap | €35.38b |
| Earnings (TTM) | €1.86b |
| Revenue (TTM) | €102.08b |
19.0x
P/E Ratio0.3x
P/S RatioIs HUM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HUM income statement (TTM) | |
|---|---|
| Revenue | US$109.24b |
| Cost of Revenue | US$91.66b |
| Gross Profit | US$17.58b |
| Other Expenses | US$15.59b |
| Earnings | US$1.99b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 01, 2024
| Earnings per share (EPS) | 16.52 |
| Gross Margin | 16.10% |
| Net Profit Margin | 1.82% |
| Debt/Equity Ratio | 83.7% |
How did HUM perform over the long term?
See historical performance and comparison